Scientists often rely on cutting-edge tools to understand how cells behave, especially when studying complex environments like the human lungs. Researchers at the University of British Columbia describe how combining two technologies, single-cell RNA sequencing (sc-RNA-seq) and cytometry by time-of-flight (CyTOF), can offer a more complete understanding of immune cells found in lung fluid, known as bronchoalveolar lavage (BAL).

BAL samples are often collected during clinical procedures to investigate lung health or disease. These samples contain a mix of immune cells, including macrophages and T cells, that play key roles in defending the lungs against infection and inflammation. Understanding what these cells are doing can help scientists detect early signs of diseases like asthma, COPD, or even lung cancer.

Why combine RNA and protein analysis?

Traditionally, scientists use single-cell RNA sequencing to analyze the genes active in individual cells. This tells us which proteins a cell could produce, offering clues about its identity and potential behavior. But RNA doesn’t always tell the whole story. Just because a gene is active doesn’t mean its corresponding protein is being made, or functioning correctly. CyTOF measures the actual proteins present on or inside cells, offering a real-time view of what’s really happening.

In this study, the researchers applied both sc-RNA-seq and CyTOF to the same BAL samples from healthy participants. They wanted to know: How well do RNA and protein data match up when identifying cell types and their activity?

Findings

At a broad level, the two techniques generally agreed on the main immune cell types in the lungs. However, when the researchers zoomed in on specific subpopulations, especially macrophages, they noticed discrepancies. The RNA and protein data often told different stories about these cells, suggesting that RNA levels alone might not accurately reflect macrophage behavior. On the other hand, T-lymphocytes showed better agreement between RNA and protein profiles.

Despite these differences, overall gene and protein expression levels were significantly correlated (p < 0.01), supporting the idea that RNA sequencing is a powerful tool, but it becomes even more reliable when validated with protein-level data.

Importance

This research highlights a key point in modern biology: no single technique can tell you everything. RNA sequencing is incredibly useful, especially for identifying unknown cell types and understanding gene regulation. But proteins are the actual workhorses of the cell, so knowing which ones are present, and in what amounts, adds crucial context.

By recommending CyTOF as a complementary tool to sc-RNA-seq, especially for specific proteins and cell types like macrophages in BAL samples, the authors are encouraging more rigorous and holistic approaches to lung immunology research. This dual-method approach could help scientists better track disease progression, discover new biomarkers, and eventually develop more personalized treatments for lung conditions.

In summary, combining RNA and protein data helps researchers move from what cells say they’ll do to what they’re actually doing. That’s a big step toward understanding how our immune systems keep us healthy, and what goes wrong when they don’t.